Top Markets
#1 Fabric Protocol Fabric Protocol +29.17%
#2 The Black Bull The Black Bull +28.64%
#3 Ethena Staked ENA Ethena Staked ENA +28.15%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +27.44%
#5 Bitcoin Cash Bitcoin Cash +26.84%
#6 HashKey Platform Token HashKey Platform Token +26.07%
#7 GALA GALA +25.71%
#8 Zora Zora +24.31%
#9 Pieverse Pieverse +23.14%
#10 Prom Prom +23.08%
Coin of the day
Fabric Protocol Fabric Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Rang in aandelen #24698
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Aandeelprijs
$0.95011029
Laatst gesynchroniseerd: 2023-06-28
Marktkapitalisatie
$57.72M
Verandering (1 dag)
8.53%
Verandering (1 jaar)
0.00%
Land
FR
Handel ERYTECH Pharma S.A. (ERYP)

Categorie

Healthcare
P/B-ratio voor ERYTECH Pharma S.A. (ERYP)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van ERYTECH Pharma S.A. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor ERYTECH Pharma S.A. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH